U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Premarket Notification Submissions for Empty Containers for the Collection and Processing of Blood and Blood Components
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Premarket Notification Submissions for Empty Containers for the Collection and Processing of Blood and Blood Components Guidance for FDA Reviewers July 2001

Download the Final Guidance Document
Final
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research

This guidance presents an overview of the type of information FDA reviewers should expect to be included in the premarket notifications submitted for such devices and the approach FDA reviewers normally should take in reviewing premarket submissions for empty containers for the collection and processing of blood and blood components used in blood establishments. The detailed requirements for premarket notifications in 21 CFR Part 807 should also be consulted.

Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Questions?

Back to Top